MicroRNA-16 represses colorectal cancer cell growth in vitro by regulating the p53/survivin signaling pathway

Oncology Reports

Volumn 29, Issue 4, 2013, Pages 1652-1658

  Ma, Qunying ^a   Wang, Xinying ^a   Li, Zhao ^a   Li, Bingsheng ^a   Ma, Fengli ^a   Peng, Liang ^a   Zhang, Yu ^a   Xu, Angao ^b   Jiang, Bo ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b Huizhou First Hospital   (China)

Author keywords

Apoptosis; Cell proliferation; Colorectal cancer; MicroRNA; MiR 16; P53; Survivin

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 6; MESSENGER RNA; MICRORNA 16; PROTEIN P53; SURVIVIN;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; GENE REPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MAJOR CLINICAL STUDY; ONCOGENE; ONCOGENE SURVIVIN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

CELL PROLIFERATION; COLORECTAL NEOPLASMS; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MICRORNAS; MOLECULAR TARGETED THERAPY; NEOPLASM STAGING; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84874686245     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2262     Document Type: Article

References (27)

1. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
2. Friedman RC, Farh KK, Burge CB and Bartel DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19: 92-105, 2009.
3. Calin GA, Dumitru CD, Shimizu M, et al: Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 99: 15524-15529, 2002.
4. Bandi N, Zbinden S, Gugger M, et al: miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer. Cancer Res 69: 5553-5559, 2009.
5. Bhattacharya R, Nicoloso M, Arvizo R, et al: miR-15a and miR-16 control Bmi-1 expression in ovarian cancer. Cancer Res 69: 9090-9095, 2009.
6. Bonci D, Coppola V, Musumeci M, et al: The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat Med 14: 1271-1277, 2008.
7. Aqeilan RI, Calin GA and Croce CM: miR-15a and miR-16-1 in cancer: discovery, function and future perspectives. Cell Death Differ 17: 215-220, 2010.
8. Cimmino A, Calin GA, Fabbri M, et al: miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 102: 13944-13949, 2005.
9. Tsang WP and Kwok TT: Epigallocatechin gallate up-regulation of miR-16 and induction of apoptosis in human cancer cells. J Nutr Biochem 21: 140-146, 2010.
10. Boominathan L: The tumor suppressors p53, p63, and p73 are regulators of microRNA processing complex. PLoS One 5: e10615, 2010.
11. Suzuki HI, Yamagata K, Sugimoto K, Iwamoto T, Kato S and Miyazono K: Modulation of microRNA processing by p53. Nature 460: 529-533, 2009.
12. Alexander D, Jhala N, Chatla C, et al: High-grade tumor differ¬entiation is an indicator of poor prognosis in African Americans with colonic adenocarcinomas. Cancer 103: 2163-2170, 2005.
13. Feng S, Cong S, Zhang X, et al: MicroRNA-192 targeting retino¬blastoma 1 inhibits cell proliferation and induces cell apoptosis in lung cancer cells. Nucleic Acids Res 39: 6669-6678, 2011.
14. Fabbri M, Bottoni A, Shimizu M, et al: Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia. JAMA 305: 59-67, 2011.
15. Bottoni A, Piccin D, Tagliati F, Luchin A, Zatelli MC and degli Uberti EC: miR-15a and miR-16-1 down-regulation in pituitary adenomas. J Cell Physiol 204: 280-285, 2005.
16. Yip KW, Shi W, Pintilie M, et al: Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer. Clin Cancer Res 12: 5726-5732, 2006.
17. Shen W, Wang CY, Wang XH and Fu ZX: Oncolytic adenovirus mediated Survivin knockdown by RNA interference suppresses human colorectal carcinoma growth in vitro and in vivo. J Exp Clin Cancer Res 28: 81, 2009.
18. Ambrosini G, Adida C and Altieri DC: A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3: 917-921, 1997.
19. Kawasaki H, Toyoda M, Shinohara H, et al: Expression of survivin correlates with apoptosis, proliferation, and angiogenesis during human colorectal tumorigenesis. Cancer 91: 2026-2032, 2001.
20. Lynch CJ and Milner J: Loss of one p53 allele results in four-fold reduction of p53 mRNA and protein: a basis for p53 haplo-insufficiency. Oncogene 25: 3463-3470, 2006.
21. Vegran F, Boidot R, Oudin C, Defrain C, Rebucci M and Lizard-Nacol S: Association of p53 gene alterations with the expression of antiapoptotic survivin splice variants in breast cancer. Oncogene 26: 290-297, 2007.
22. Hoffman WH, Biade S, Zilfou JT, Chen J and Murphy M: Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J Biol Chem 277: 3247-3257, 2002.
23. Murphy M, Ahn J, Walker KK, et al: Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a. Genes Dev 13: 2490-2501, 1999.
24. Mirza A, McGuirk M, Hockenberry TN, et al: Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway. Oncogene 21: 2613-2622, 2002.
25. Raj D, Liu T, Samadashwily G, Li F and Grossman D: Survivin repression by p53, Rb and E2F2 in normal human melanocytes. Carcinogenesis 29: 194-201, 2008.
26. Yang X, Xiong G, Chen X, et al: Survivin expression in esophageal cancer: correlation with p53 mutations and promoter polymorphism. Dis Esophagus 22: 223-230, 2009.
27. Suh SO, Chen Y, Zaman MS, et al: MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer. Carcinogenesis 32: 772-778, 2011.